Form 4: Oscar Health Executive Acquires Restricted Stock Units

Alessandrea C. Quane, EVP and Chief Insurance Officer of Oscar Health, Inc., acquired 103,829 restricted stock units on March 10, 2024.

Summary

• On March 10, 2024, Alessandrea C. Quane, the EVP, Chief Insurance Officer of Oscar Health, Inc., acquired 103,829 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of Class A common stock each.
• The units will vest over a three-year period, with 12 equal quarterly installments starting on June 1, 2024.
• Following the transaction, Ms. Quane directly owns 103,829 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing and doesn't inherently convey positive or negative sentiment. It's a neutral disclosure of an executive's stock acquisition.

Future Outlook

The restricted stock units will vest over a three-year period, starting June 1, 2024, potentially increasing Ms. Quane's holdings of Class A common stock over time.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It provides transparency into the equity holdings of company insiders.

Stakeholder Impact

• The acquisition of restricted stock units by a key executive could be viewed positively by shareholders, as it aligns the executive's interests with the company's long-term performance.

Key Dates